“…While much development has been made with respect to arylation,– acylation,– amination,– phosphonylation– directly at the C3 position using easily available quinoxalin‐2(1 H )‐ones, functionalization by benzyl, alkyl and fluoroalkyl groups are less explored, despite the importance and predominance of this scaffold as pharmaceuticals that include MDR antagonist, aldose reductase inhibitor, MAO‐A inhibitor, ion channel blocker, antitumor, anti‐inflamatory, and antiobesity agents (Figure ) . Very recently, C3 position of quinoxalin‐2(1 H )‐one has been directly benzylated and alkylated using methylarenes and ethers, respectively (Scheme a). Three reports describing cyanoalkylation at the C3 of quinoxalin‐2(1 H )‐one have been very recently disclosed (Scheme b).…”